Tag: pharma QA

Setting Cleaning Validation Limits Using MACO and Health-Based Exposure Limits (HBELs) Step-by-Step Guide to Setting Cleaning Validation Limits Using MACO and Health-Based Exposure Limits Establishing scientifically justified cleaning validation limits is a cornerstone of process validation and ensuring ongoing GMP compliance in pharmaceutical manufacturing. This tutorial provides a comprehensive, stepwise approach for pharmaceutical quality assurance…

Read More “Setting Cleaning Validation Limits Using MACO and Health-Based Exposure Limits (HBELs)” »

Process Validation in Contract Manufacturing (CMOs/CDMOs): Roles and Oversight Comprehensive Guide to Process Validation, CPV, and Cleaning Validation in Contract Manufacturing Pharmaceutical companies increasingly rely on Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) to produce drug products and active pharmaceutical ingredients (APIs). Ensuring robust process validation and comprehensive cleaning validation underpins…

Read More “Process Validation in Contract Manufacturing (CMOs/CDMOs): Roles and Oversight” »

Risk-Based Re-Validation: When Is Re-Qualification Required? Risk-Based Re-Validation: When Is Re-Qualification Required? In pharmaceutical manufacturing, maintaining GMP compliance requires a robust and well-documented validation strategy covering process validation, cleaning validation, and ongoing product/process monitoring such as continued process verification (CPV). A critical part of this strategy is determining when re-validation or re-qualification is needed to…

Read More “Risk-Based Re-Validation: When Is Re-Qualification Required?” »

Scale-Up and Scale-Down Models Used in Validation Justifications Understanding Scale-Up and Scale-Down Models in Validation Justifications: A Step-by-Step GMP Tutorial In pharmaceutical manufacturing, process validation and cleaning validation are critical elements to achieving and maintaining GMP compliance. Among the essential components of robust validation strategies is the use of scale-up and scale-down models which facilitate…

Read More “Scale-Up and Scale-Down Models Used in Validation Justifications” »

Using DoE Data in Process Validation: Statistical Rigor and Regulatory Use Leveraging DoE Data for Robust Process Validation and Regulatory Compliance in Pharma Pharmaceutical manufacturing requires strict adherence to Good Manufacturing Practice (GMP) regulations to ensure product quality, safety, and efficacy. Among critical quality initiatives, process validation stands out as a fundamental pillar, guaranteeing that…

Read More “Using DoE Data in Process Validation: Statistical Rigor and Regulatory Use” »

Linking Development Studies to Final PPQ Protocols Linking Development Studies to Final PPQ Protocols: A Step-by-Step GMP Tutorial In pharmaceutical manufacturing, the transition from development studies to the final Process Performance Qualification (PPQ) protocols is a critical phase underpinning GMP compliance. Process validation, including continued process verification (CPV) and cleaning validation, ensures consistent product quality…

Read More “Linking Development Studies to Final PPQ Protocols” »

Integrating CPV Outputs With CAPA, Deviations and Change Control Comprehensive Step-by-Step Guide to Integrating CPV Outputs With CAPA, Deviations, and Change Control Pharmaceutical manufacturing requires not only rigorous process validation but also effective integration of continued process verification (CPV) outputs into the broader quality management system. This integration is critical for maintaining GMP compliance, facilitating…

Read More “Integrating CPV Outputs With CAPA, Deviations and Change Control” »

CPV for Low-Volume, Niche and Rare-Disease Products Continued Process Verification for Low-Volume, Niche and Rare-Disease Pharmaceutical Products: A Step-by-Step Tutorial Pharmaceutical manufacturers producing low-volume, niche, or rare-disease products face unique challenges in maintaining quality and compliance under Good Manufacturing Practice (GMP) regulations. Core elements such as process validation, continued process verification (CPV), and cleaning validation…

Read More “CPV for Low-Volume, Niche and Rare-Disease Products” »

CPV for Low-Volume, Niche and Rare-Disease Products: A Comprehensive GMP Guide Continued Process Verification and Cleaning Validation for Low-Volume and Rare-Disease Products Pharmaceutical manufacturers producing low-volume, niche, and rare-disease products face unique challenges in achieving robust GMP compliance and sustaining quality throughout the product lifecycle. Critical components of the validation lifecycle such as process validation,…

Read More “CPV for Low-Volume, Niche and Rare-Disease Products” »

CPV in Continuous Manufacturing: Real-Time Monitoring and Response Continued Process Verification (CPV) in Continuous Manufacturing: A Step-by-Step GMP Tutorial Continuous manufacturing of pharmaceutical products is gaining significant traction across the US, UK, and EU markets due to its flexibility, efficiency, and potential to enhance product quality. However, the inherent complexities of continuous processing necessitate robust…

Read More “CPV in Continuous Manufacturing: Real-Time Monitoring and Response” »